Indian billionaire investor Rakesh Jhunjhunwala says he's very upbeat about his country's growth potential after the country underwent a massive banking crisis and the rollout...Asia Economyread more
There's more pain ahead for the U.S. and China amid their bilateral trade dispute, according to one expert.China Politicsread more
The U.S. government on Monday temporarily eased some trade restrictions imposed recently on China's Huawei, a move that sought to minimize disruption for the telecom company's...Technologyread more
You know there's an underlying problem when investment firms start to cut exposure to a particular asset class.Commentaryread more
Stocks in Asia mostly recovered in Tuesday afternoon trade as investors cheered a reprieve in U.S.-China trade tensions surrounding Chinese telecommunications giant Huawei.Asia Marketsread more
The issue of corporate debt has surfaced as companies continue to use the low rates the Fed has provided to lever up their balance sheets.The Fedread more
A record 257.4 million travelers are expected to opt for U.S. airlines for travel this summer, the 10th consecutive annual increase, a trade group forecast on Tuesday.Airlinesread more
Huya, a Chinese live streaming platform focused on gaming, is looking to expand into the U.S. in the next couple of years, CEO Rongjie Dong told CNBC. The U.S. is expected to...Technologyread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
Mall owners are increasingly building out food halls with local chef-driven eateries, sushi bars and premium coffee shops.Retailread more
While Trump's lawyers had argued that the committee's subpoena did not have a legitimate legislative purpose — and was therefore invalid — Mehta took a broader view.Politicsread more
Magellan Midstream Partners, L.P.: "It's going higher. I beat myself up on a [charitable trust] club call today for ActionAlertsPlus saying, 'Listen, I thought that FERC was going to derail these guys. I was wrong.' The company did an amazing job. [CEO] Michael Mears came on this show when the stock was really, really low and said, 'Buy it.' He was right."
Xylem, Inc.: "Like we said last night, we like anything water-connected. It's come down a little bit. It's still up for the year. I'm going to reiterate to buy."
Karyopharm Therapeutics: "You're out there on your own, I've got to tell you, because that is a very, very speculative situation for a billion-dollar company and I cannot endorse it here."
New Residential Investment Corp.: "Very high yield. Don't know whether it can be backed up. Why? Because I don't really know what they own. That's the problem with some of these higher yielders. They've got mortgages [and] I can't figure out whether they're good or not. I'm taking a pass."
Kemet Corporation: "Inexpensive semiconductor company that I think is worth buying. I know it's a little speculative but I think it's a good one."
Iovance Biotherapeutics, Inc.: "Look, we have always said the same thing: oncological specs we are willing to accept as long as we understand that they are specs and nothing more because they tend to get takeover bids."
Casella Waste Systems, Inc.: "I've known them for many years. Used to have a position in them many, many years ago when I was a hedge fund manager. I've got to tell you, I think you should be in Waste Management. Let's go for big and best. Let's go for best of breed. "
Boston Scientific Corporation: "No, no, no, [don't buy more]. In fact, I want you to take our your cost basis tomorrow and play with the house's money. [CEO Michael] Mahoney's doing an unbelievable job. We did not see that takeover bid materialize. I don't care. It's an earnings story and they are a remarkable company."